Hasil Pencarian - Francesco Angotzi
- Menampilkan 1 - 12 hasil dari 12
-
1
Tackling the dysregulated immune-checkpoints in classical Hodgkin lymphoma: bidirectional regulations between the microenvironment and Hodgkin/Reed-Sternberg cells oleh Alessandro Cellini, Federico Scarmozzino, Francesco Angotzi, Edoardo Ruggeri, Angelo Paolo Dei Tos, Livio Trentin, Marco Pizzi, Andrea Visentin
Diterbitkan 2023-05-01
Artikel -
2
Primary Myelofibrosis Occurring during Targeted Therapy for Chronic Lymphocytic Leukemia: A Report of Two Cases oleh Francesco Angotzi, Andrea Visentin, Federico Scarmozzino, Alessandro Cellini, Roberta Bertorelle, Marco Pizzi, Gianni Binotto, Angelo Paolo Dei Tos, Livio Trentin
Diterbitkan 2022-02-01
Artikel -
3
Multiple specialized stem cell niches characterize hematopoiesis in the human fetal liver oleh Daniela Fanni, Francesco Angotzi, Clara Gerosa, Doris Barcellona, Giancarlo Senes, Federica Lai, Giovanni Martino, Stefano Ascani, Vassilios Fanos, Gavino Faa
Diterbitkan 2020-02-01
Artikel -
4
Efficacy and safety of venetoclax plus hypomethylating agents in relapsed/refractory acute myeloid leukemia: a multicenter real-life experience oleh Francesco Angotzi, Federica Lessi, Matteo Leoncin, Carla Filì, Mauro Endri, Albana Lico, Andrea Visentin, Stefano Pravato, Anna Candoni, Livio Trentin, Carmela Gurrieri
Diterbitkan 2024-04-01
Artikel -
5
A Retrospective Study on the Efficacy of Subcutaneous Immunoglobulin as Compared to Intravenous Formulation in Patients with Chronic Lymphocytic Leukemia and Secondary Antibody Def... oleh Andrea Visentin, Maria Chiara Molinari, Stefano Pravato, Alessandro Cellini, Francesco Angotzi, Chiara Adele Cavaretta, Valeria Ruocco, Silvia Imbergamo, Francesco Piazza, Giulia Proietti, Francesca Romana Mauro, Livio Trentin
Diterbitkan 2022-12-01
Artikel -
6
P054: The Kinase CK2 is deregulated and targetable in classical Hodgkin Lymphoma oleh Andrea Visentin, Edoardo Ruggeri, Federica Frezzato, Marco Pizzi, Alessandro Cellini, Francesco Angotzi, Chiara Adele Cavarretta, Valeria Ruocco, Stefano Pravato, Filippo Severin, Monica Facco, Sabrina Manni, Francesci Piazza, Livio Trentin
Diterbitkan 2022-10-01
Artikel -
7
Baseline prognostic predictors in classical Hodgkin Lymphoma: a retrospective, single-center analysis on patients treated with PET/CT-guided ABVD oleh Alessandro Cellini, Chiara Adele Cavarretta, Francesco Angotzi, Valeria Ruocco, Andrea Serafin, Nicolò Danesin, Marco Pizzi, Michele Gregianin, Stefania Vio, Filippo Crimì, Federica Vianello, Francesco Piazza, Livio Trentin, Andrea Visentin
Diterbitkan 2024-09-01
Artikel -
8
P1075: ADVANCED-STAGE CHL INTERNATIONAL PROGNOSTICATION INDEX: EXTERNAL VALIDATION IN A SINGLE-CENTER RETROSPECTIVE PATIENT DATASET AND COMPARISON TO THE HASENCLEVER IPS oleh Alessandro Cellini, Chiara Adele Cavarretta, Francesco Angotzi, Valeria Ruocco, Andrea Serafin, Ivan Zatta, Michele Gregianin, Stefania Vio, Filippo Crimì, Federica Vianello, Marco Pizzi, Stefano Pravato, Livio Trentin, Andrea Visentin
Diterbitkan 2023-08-01
Artikel -
9
P005: Age, histotype and stage IV are associated with a shorter survival in patients with Hodgkin lymphoma, even the PET-adapted era. A single center retrospective study. oleh Andrea Visentin, Alessandro Cellini, Chiara Adele Cavarretta, Leila Romano Gargarella, Francesco Angotzi, Valeria Ruocco, Simone Zoletto, Stefano Pravato, Marco Pizzi, Federica Vianello, Filippo Crimì, Stefania Vio, Michele Gregianin, Livio Trentin
Diterbitkan 2022-10-01
Artikel -
10
Protein kinase CK2α is overexpressed in classical hodgkin lymphoma, regulates key signaling pathways, PD-L1 and may represent a new target for therapy oleh Edoardo Ruggeri, Federica Frezzato, Nayla Mouawad, Marco Pizzi, Federico Scarmozzino, Guido Capasso, Valentina Trimarco, Laura Quotti Tubi, Alessandro Cellini, Chiara Adele Cavarretta, Valeria Ruocco, Andrea Serafin, Francesco Angotzi, Nicolò Danesin, Sabrina Manni, Monica Facco, Francesco Piazza, Livio Trentin, Andrea Visentin
Diterbitkan 2024-05-01
Artikel -
11
Tixagevimab/Cilgavimab as pre-exposure prophylaxis against SARS-CoV-2 in patients with hematological malignancies oleh Francesco Angotzi, Marco Petrella, Tamara Berno, Gianni Binotto, Giorgia Bonetto, Antonio Branca, Marco Carraro, Chiara Adele Cavaretta, Alessandro Cellini, Fabio D’Amore, Laura Forlani, Ilaria Gianesello, Carmela Gurrieri, Silvia Imbergamo, Federica Lessi, Antonio Maroccia, Federica Mazzetto, Laura Pavan, Sara Pezone, Francesco Piazza, Stefano Pravato, Valeria Ruocco, Greta Scapinello, Fabrizio Vianello, Renato Zambello, Ivan Zatta, Simone Zoletto, Andrea Padoan, Livio Trentin, Andrea Visentin
Diterbitkan 2023-06-01
Artikel -
12
Obinutuzumab plus chlorambucil versus ibrutinib in previously untreated chronic lymphocytic leukemia patients without TP53 disruptions: A real-life CLL campus study oleh Andrea Visentin, Andrea Visentin, Francesca Romana Mauro, Gioachino Catania, Alberto Fresa, Candida Vitale, Alessandro Sanna, Veronica Mattiello, Francesca Cibien, Paolo Sportoletti, Massimo Gentile, Gian Matteo Rigolin, Francesca Maria Quaglia, Roberta Murru, Alessandro Gozzetti, Stefano Molica, Monia Marchetti, Stefano Pravato, Francesco Angotzi, Alessandro Cellini, Lydia Scarfò, Gianluigi Reda, Marta Coscia, Luca Laurenti, Paolo Ghia, Robin Foà, Antonio Cuneo, Livio Trentin, Livio Trentin
Diterbitkan 2022-11-01
Artikel